ALIS (Amikacin Liposome Inhalation Suspension): The Beginning of a Wonderland?
Am J Respir Crit Care Med
.
2018 Dec 15;198(12):1473-1475.
doi: 10.1164/rccm.201810-1901ED.
Authors
Charles L Daley
1
2
,
Kenneth N Olivier
3
Affiliations
1
Department of MedicineNational Jewish HealthDenver, Colorado.
2
University of ColoradoAurora, Coloradoand.
3
Pulmonary BranchNational Heart, Lung, and Blood InstituteBethesda, Maryland.
PMID:
30365392
PMCID:
PMC7212798
DOI:
10.1164/rccm.201810-1901ED
No abstract available
Publication types
Editorial
Comment
MeSH terms
Amikacin
Humans
Liposomes
Lung Diseases*
Mycobacterium avium Complex
Mycobacterium avium-intracellulare Infection*
Prospective Studies
Substances
Liposomes
Amikacin